Skyhawk Therapeutics Receives HREC Approval for a Phase 1 Study of its SKY-0515 RNA-Targeting Small





- May 16
Drugging RNA


- Sep 6, 2022
Drugging RNA with Pills : Small Molecules for a Big Frontier


- Jul 6, 2022
Skyhawk Announces Collaboration Agreement with Sanofi for Oncology and Immunology Targets


- Jul 5, 2022
Bill Haney’s latest startup scores deal from Sanofi its newest Big Pharma partner, with $54M upfront


- Sep 13, 2021
Bill Haney adds another $133M to Skyhawk’s coffers, as the RNA startup guns for the clinic


- Sep 13, 2021
Skyhawk Therapeutics Completes New Investment Round


- Apr 12, 2021
Skyhawk Therapeutics Expands Leadership Team, Appointing Elliot Ehrich MD as President and ...


- Dec 22, 2020
$40M up front: Skyhawk takes flight with Vertex deal


- Dec 22, 2020
Vertex joins Skyhawk’s roster of A-list partners, securing options on RNA splicing modulators


- Dec 22, 2020
A busy, buzzy Vertex finds a high-profile partner in the RNA-drugging world to launch a fresh ...


- Sep 29, 2020
The Endpoints 11 : Here are some of the most promising startups in biotech. And Covid-19 isn’t ...

Skyhawk News